Our goal in this project is to establish biological understanding, preclinical proof of concept;and safety data using AAV-based vectors for correction of familial hypercholesterolemia (FH) and abetalipoproteinemia (ABL) such that clinical trials of gene therapy for both disorders is a tangible reality by the final year of this P01. Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD), the most common cause of death and disability. Several common genetic forms of dyslipidemia exist and although many patients with dyslipidemia can be treated effectively with existing drugs, others are not effectively treated and remain at exceptionally high risk of premature ASCVD. A classic example is homozygous FH, in which patients have severe hypercholesterolemia that can't be effectively treated with current drugs and develop ASCVD in childhood or adolescence. Conversely, ABL, which is due to mutations in the microsomal triglyceride transfer protein (MTP), is associated with absent plasma LDL and apoB and progressive spinocerebellar degeneration and retinopathy. Therefore, understanding of the regulation of the secretion and catabolism of apoB-containing lipoproteins by the liver is of major importance to the development of new therapies targeted toward these pathways. Liver-directed somatic gene transfer is a useful biological tool that could be used as a strategy for treating severe dyslipidemia. In this project, we will utilize liver-directed gene transfer using vectors based on novel adeno-associated virus (AAV) pseudotypes to address questions related to the impact of specific gene products on the regulation of hepatic secretion of apoBcontaining lipoproteins. Project I will identify the best AAV for liver-directed gene transfer (called AAVcc) which will be further evaluated in this project.
Specific Aim 1 will use mouse models of FH to test the hypothesis that AAVcc-mediated expression of the murine LDL receptor (LDLR) will stably normalize cholesterol levels and prevent, and regress, atherosclerosis.
Specific Aim 2 will test the hypothesis that AAV8-mediated expression of the rabbit LDL receptor (LDLR) will stably normalize cholesterol levels and prevent, and regress, atherosclerosis in LDLR-deficient WHHL rabbits.
Specific Aim 3 will test the hypothesis that AAVcc-mediated expression of the rhesus LDL receptor (LDLR) wilj stably normalize cholesterol levels in the heterozygous LDLR-deficient rhesus fed a high-fat high-cholesterol diet designed to downregulate the expression of the LDLR from the normal allele.
Specific Aim 4 will test the hypothesis that AAVcc-mediated expression of the murine MTP will stably permit secretion of apoB-containing lipoproteins by the liver in the liver-deficient MTP mouse. Effects on vitamin E metabolism and end-organ effects will also be determined.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL059407-15
Application #
8502516
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
15
Fiscal Year
2013
Total Cost
$379,448
Indirect Cost
$125,192
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ibrahim, Salam; Somanathan, Suryanarayan; Billheimer, Jeffrey et al. (2016) Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol. Cardiovasc Res 110:23-9
Ajufo, Ezim; Cuchel, Marina (2016) Recent Developments in Gene Therapy for Homozygous Familial Hypercholesterolemia. Curr Atheroscler Rep 18:22
Rashnonejad, Afrooz; Chermahini, Gholamhossein Amini; Li, Shaoyong et al. (2016) Large-Scale Production of Adeno-Associated Viral Vector Serotype-9 Carrying the Human Survival Motor Neuron Gene. Mol Biotechnol 58:30-6
Halder, Sujata; Van Vliet, Kim; Smith, J Kennon et al. (2015) Structure of neurotropic adeno-associated virus AAVrh.8. J Struct Biol 192:21-36
Xie, Jun; Burt, Daniel Robert; Gao, Guangping (2015) Adeno-associated virus-mediated microRNA delivery and therapeutics. Semin Liver Dis 35:81-8
Bissig-Choisat, Beatrice; Wang, Lili; Legras, Xavier et al. (2015) Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nat Commun 6:7339
Wang, Lili; Bell, Peter; Somanathan, Suryanarayan et al. (2015) Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids. Mol Ther 23:1877-87
Wang, Qiang; Lock, Martin; Prongay, Andrew J et al. (2015) Identification of an adeno-associated virus binding epitope for AVB sepharose affinity resin. Mol Ther Methods Clin Dev 2:15040
Ahmed, Seemin S; Gao, Guangping (2015) Making the White Matter Matters: Progress in Understanding Canavan's Disease and Therapeutic Interventions Through Eight Decades. JIMD Rep 19:11-22
Wang, Dan; Gao, Guangping (2014) State-of-the-art human gene therapy: part I. Gene delivery technologies. Discov Med 18:67-77

Showing the most recent 10 out of 140 publications